A carregar...
One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial
OBJECTIVE: Traditional blood glucose–lowering agents do not sustain adequate glycemic control in most type 2 diabetic patients. Preclinical studies with exenatide have suggested sustained improvements in β-cell function. We investigated the effects of 52 weeks of treatment with exenatide or insulin...
Na minha lista:
Main Authors: | , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Diabetes Association
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2671094/ https://ncbi.nlm.nih.gov/pubmed/19196887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-1797 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|